Introduction
For patients with suspected coronary artery disease (CAD), invasive coronary angiography (ICA) is the gold standard diagnostic anatomical test after an initial clinical assessment. 1, 2 Coronary angiography findings are most commonly categorized into three groups: (i) normal, (ii) minor atherosclerosis but no obstructive disease (wall changes), and (iii) obstructive coronary disease. Patients with normal coronary arteries have the best prognosis but still have higher mortality than the general population. Individuals with normal arteries on angiography should be evaluated for preventive cardiovascular medication after risk score evaluation. 3 Patients with wall changes have established atherosclerosis and will require preventive cardiovascular medication and follow-up. Those with obstructive coronary disease are high-risk patients in need of both cardiovascular prevention and treatment with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). 1 Additional functional testing of the fractional flow reserve in patients with an anatomical obstruction of > _50% has improved the selection of patients who will benefit from revascularization. 4 In patients with stable coronary disease, the yield of coronary angiography is low; obstructive CAD was found in only 37% of patients in a large study. 5 Patients referred for ICA due to suspected obstructive coronary disease are a heterogeneous group regarding the presence and prevalence of CAD. Regardless of their coronary status, these patients experience a negative impact on their perception of health and quality of life. [6] [7] [8] [9] Patients awaiting ICA have demonstrated increased levels of anxiety, and studies have described interventions aimed at alleviating pre-procedural distress and anxiety. 10, 11 The diagnostic result of ICA, usually communicated to the patient during or immediately after the diagnostic procedure, can have an immediate effect on emotions and symptoms, according to previous research. 12 In a study conducted before and within hours after ICA, in patients both with and without previous CAD, the number of symptoms, the perception of the consequences of the illness and illness-related emotions were decreased for patients diagnosed with normal vessels but remained unchanged for patients who were diagnosed with diseased arteries. 12 To what extent these changes persist over time is unknown. Further, contradictory results are reported where receipt of negative diagnostic result did not relieve negative emotions. 13 Correspondingly, in a study that compared the levels of anxiety and depression in patients with non-obstructive CAD with the general population, both men and women reported significantly higher levels of anxiety and depression than the age-and gender-matched reference population. 9 To our knowledge, studies that examine changes in symptoms following the receipt of diagnostic results have not examined the effect of the detection of non-obstructive wall changes. In a large retrospective cohort study of patients with non-obstructive CAD compared to patients without apparent CAD, the former group exhibited a significant increase in the risk for both myocardial infarction (MI) and all-cause mortality after 1 year. 14 Additionally, a paucity of research exists about the effects on symptoms of anxiety and depression over time after receiving the diagnostic results of coronary angiography. Previous studies have not, to the best of our knowledge, followed patients prospectively, differentiated between degrees of non-obstructive stenosis or examined patients without a previous diagnosis of CAD. The aim of this study was therefore to prospectively follow stable patients without a previous diagnosis of CAD to explore the impact of the diagnostic results on changes in symptoms of anxiety and depression 6 and 12 months after diagnostic angiography and, furthermore, to analyse the predictors of symptoms of anxiety and depression after 12 months in the entire cohort.
Methods

Design and population
The study is part of a larger cohort study with an all-comers prospective design that includes patients who were evaluated in 2012 at University Hospital of North Norway, Tromsø, Norway. The aim of the larger study was to evaluate the performance of modern computed tomography coronary angiography (CTCA) compared to that of conventional ICA; the clinical trial identifier is NCT01476579. Patients were included consecutively after referral and accepted for elective ICA based on clinical information from the referring physician, independent of the study. Exclusion criteria included renal insufficiency, known contrast medium allergy, serious comorbidity, pregnancy, unstable angina, or resent acute coronary syndrome. The larger study included a total of 768 patients: 459 without previous known CAD and 309 with known CAD. In this study, 459 patients without a previous diagnosis of CAD were included and followed prospectively as a cohort. Patients with established CAD were excluded, as the impact on mood was expected to be different, as the test would not change their disease status.
Written informed consent was collected from patients who agreed to participate in the study. The trial was approved by the regional board of ethics and conformed to the principles of the Helsinki declaration.
Invasive coronary angiography
Cardiologists with >5 years of experience with interventional treatment performed the ICA procedures blinded to the treatment groups. Luminal narrowing was classified as percent luminal diameter stenosis based on visual estimation and categorized as normal (0-20%), wall changes (21-49%), and obstructive stenosis (50-100%). Based on the physician's final decision, the treatment of the patient was categorized as no treatment, medical treatment, PCI, or CABG according to the guideline recommendations. 1 
Data collection
Data were collected at baseline and after 6 and 12 months using a clinical assessment, medical chart, and self-reports from the patients. Sociodemographic and clinical data collected at baseline included age, gender, body mass index, marital status/cohabitation, employment status, previous diabetes diagnosis, hypercholesterolaemia (treated with statins), hypertension and atrial fibrillation, previous smoking and smoking habits, levels of physical activity, and diagnostic results after ICA.
Symptoms of anxiety and depression were assessed with the Hospital Anxiety and Depression Scale (HADS) 15, 16 using self-report before the angiography and after 6 and 12 months. The HADS consists of two 7-item subscales for symptoms of anxiety (HADS-A) and depression (HADS-D). The scale is developed for somatic patients and is not affected by physical symptoms. Response options on all 14 items are based on a category scale ranging from 0 to 3; higher scores indicate more symptoms, and each subscale has a possible range from 0 to 21. Optimal cutoff scores of at least 8 on both scales identify possible cases of anxiety or depressive disorders. 17 The HADS has demonstrated good psychometric properties and has been previously extensively used in cardiac patients and in Norwegian population surveys.
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The response rates after 6 and 12 months were 79% and 78%, respectively. Those not responding after 6 months were significantly younger (61.5 years vs. 64.2 years), more likely to be working full time (36.6% vs. 24.2%), and to be daily smokers (20.8% vs. 12 .6%), compared with those responding. Of the other characteristics, including symptoms of anxiety and depression, there were no significant baseline differences among responders and non-responders.
Statistical analysis
Descriptive statistics for continuous variables with approximately normal distributions and non-normal distributions were presented as the means and standard deviations. For categorical variables, the number of patients and the corresponding percentage were described. To analyse the differences in the clinical and demographical variables and HADS among the three diagnostic groups at baseline and at the different measurement points, an analysis of variance (ANOVA) with a post hoc comparison using least significant difference and the v 2 test were used, as appropriate. To test for effects over time, ANOVA with repeated measures using the general linear module (GLM) was performed with SPSS Version 22. 19 Predictors of moderate-to-severe symptoms of anxiety and depression after 12 months, HADS-A and HADS-D scores equal to or above 8, were analysed via binary logistic regression in SPSS. The following variables were included: age, gender, cohabitation, sick-listed, diabetes, hypercholesterolaemia, daily smoking, light physical activity, baseline HADS-A or HADS-D scores > _8, and ICA diagnostic results. In the unadjusted and fully adjusted models, odds ratio and its confidence interval were reported for the predictors with corresponding P-values from the Wald statistics. All tests were two tailed; the significance level was set at < _0. 05 .
Results
The sample of 459 patients without a previous diagnosis of CAD included 57% men, and the mean age of the participants was 62.1 years, as shown in Table 1 . Regarding concurrent diseases, 53% of participants had hypertension, 17% had diabetes, and 5% had atrial fibrillation. The majority of participants (74%) were living together with a spouse/partner, and 19% lived alone. Half of the participants were retired, 38% had full-or part-time employment, and 13% were on sick leave ( Table 1) . With respect to lifestyle, 48% reported at baseline to have smoked previously, and 19% were daily smokers. Approximately 55% exercised 2-3 times a week or more ( Table 1) . The results of ICA indicated that 41% had normal vessels, 21% had wall changes (20-49%), and 38% had obstructive stenosis (> _50%).
When comparing baseline characteristics among the diagnostic groups, those with normal vessels were younger and to a larger extent female. Those with significant stenosis were to a larger extent retired and had previous atrial fibrillation and hypertension ( Table 1) .
At baseline, within all three diagnostic groups, 24-26% had a HADS-A score equal to or greater than 8 ( Table 2) . Correspondingly, the proportion of patients with a HADS-D score equal to or greater than 8 at baseline ranged from 19% to 21%. A strong correlation was observed between symptoms of anxiety and depression (r = 0.66, P < 0.001). When the diagnostic groups were compared at baseline, no significant differences were found with respect to the HADS-A or HADS-D mean scores or in the proportions with scores equal to or greater than 8 ( Table 2) . At 6 months, patients with obstructive stenosis scored significantly lower than both groups without obstructive stenosis (ANOVA P = 0.022), and a significantly lower proportion had an HADS-A score greater than 8 (v 2 test P = 0.021) ( Table 2) . When change over time was analysed, significant and parallel improvements were detected in all the three diagnostic groups from baseline to 6 and 12 months for both the HADS-A and HADS-D subscales ( Table 2 ). The significant changes over time in HADS-A scores fit both a linear (P = 0.001) and quadratic (P = 0.002) model. The HADS-D subscale best fit a quadratic model (P = 0.001), whereas the linear trend was only borderline significant (P = 0.066). The quadratic relationship indicates a U-shaped trend over time; the largest improvement was from baseline to 6 months, and a higher score was detected after 12 months, which indicated the presence of additional Figure 1) . The greatest improvements were found from baseline to 6 months; the largest improvement was observed in patients with significant obstructive stenosis, and the smallest improvement was observed in patients with normal vessels, i.e. <20% stenosis ( Figure 1) . The unadjusted and adjusted models of predictors of HADS-A and HADS-D scores equal to or above 8, indicating moderate-to-severe symptoms, after 12 months, are shown in Table 3 . In the fully adjusted model, predictors of anxiety included light physical activity, diagnostic result, and baseline symptoms of anxiety. This indicate that those not performing light physical activity at least 1 h per week, already have moderate-to-severe symptoms of anxiety and have normal coronary arteries or wall changes as ICA diagnostic result were at higher risk for moderate-to-severe symptoms of anxiety after 12 months. In the fully adjusted model, predicting HADS-D equal to or above 8 after 12 months, only the HADS-D score at baseline was significant, indicating that moderate-to-severe symptoms of depression at baseline was the best predictor of moderate-to-severe symptoms of depression at 12 months.
Discussion
This is, to our knowledge, the first study to assess and show a longterm effect of the diagnostic result of angiography on pre-test anxiety and depression levels in patients without a previous diagnosis of CAD. Following the diagnostic results, both symptoms of anxiety and depression were reduced after 6 and 12 months. This finding was observed in patients with normal vessels, patients with wall changes and patients with obstructive stenosis. Patients with stenosis had lower levels of anxiety and depression at follow-up and at 6 months than patients with wall changes and normal vessels. Patients with normal vessels showed the least amount of improvement over time, but their anxiety and depression scores were not significantly different from those of patients with wall changes. Risk factors for HADS-A scores equal to or above 8 was having an elevated HADS-A score at baseline, not being physical active, and having the diagnosis of wall changes or normal arteries. Similarly, the best predictor for HADS-D score equal to or above 8 was the baseline HADS-D score, having controlled for potential confounders.
The proportions of patients with normal or non-obstructive arteries found in our study (41% and 21%, respectively) were higher than previously reported. 20 One possible explanation might be that our sample included only patients without a previous diagnosis of CAD and that our patients underwent CTCA as well; CTCA may increase the proportion of patients who are diagnosed with normal vessels or non-obstructive stenosis. 20 Our findings of higher levels of anxiety and depression before ICA with a significant reduction afterwards were consistent with both previous research and a recently published study of patients undergoing PCI for CAD. 21 The proportion of patients with anxiety or depression (i.e. a score equal to or greater than 8) who also have stenosis in this study is comparable to the proportion of patients in our previous study on Norwegian patients 12-18 months after an acute MI, 18 which indicates that long-term levels of anxiety and depression are similar to the levels reported in the Norwegian reference population.
The significantly lower level of anxiety and depression over time in patients with obstructive coronary disease possibly indicates that these patients received adequate symptom relief, CABG or PCI after the diagnosis of obstructive stenosis, in accordance with guidelines. 1 In addition, the stronger placebo effect of interventional treatment than the drug treatments is likely to contribute to our findings. 22 Patients in whom angiography does not identify a need for intervention are deprived of the catharsis inherent in a rapid revascularization with symptom relief. They are left with their pre-examination anxiety, although population studies show that a better long-term prognosis is associated with less pathology on angiography, even in patients with a diagnosis of CAD. 3 Another explanation might be that some of these patients have a concurrent psychopathological disorder. According to a study on mental symptoms in patients with cardiac symptoms and normal coronary arteries, somatoform disorders and hypochondria appeared more often in patients with normal vessels after ICA than in the reference population. 23 Thus, the recommendations to screen and examine patients for mental illness and offer specific psychological or psychiatric follow-up for these patients in clinical practice should continue because effective interventions, such as cognitive behavioural therapy, exist.
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Although ICA has long been considered a reference standard for the presence of CAD, several limitations are associated with this technique. Invasive angiography is only an anatomical description and does not contain information about plaque burden, endothelial function, or the haemodynamic properties of the coronary arteries. The Women's Ischaemia Syndrome Evaluation (WISE) study demonstrated that many patients with no CAD or with non-obstructive CAD show evidence of microvascular dysfunction, which explains the increased mortality in these groups compared to that in the general population. 25 Receiving information about normal coronary arteries when the symptoms are not relieved can be confusing for the patient and may maintain higher anxiety and depression levels. The established higher risk for patients with wall changes than for those with normal findings in the WISE study justifies the intensified preventive treatment and support of lifestyle changes in these patients.
The limitations of the study include selection bias. Not all eligible subjects in the study period could be or were willing to be included in this study. The availability and capacity at the CT laboratory was the major limiting factor, in addition to patient willingness to participate. However, as this was an all-comers study, the project group did not have any influence on the patient admittance date, which minimized the effect of selection bias. Due to ethical constraints, we did not collect data on characteristics of non-participants and reasons for non-participation. Increased anxiety and depression could, of course, be a factor for patients who did not participate in the study, as observed in previous studies. The study results cannot be generalized to the population with cardiac symptoms who, for some reason, are not referred for coronary evaluation based on a clinician's decision. Similarly, the study results cannot be generalized to the acute coronary syndrome (ACS) population who exhibit a more severe or lifethreatening clinical presentation and are transferred to another facility. The level of anxiety and depression in the ACS population at baseline and at follow-up based on angiographic findings can thus be different than in our study group, although the long-term levels are consistent with the long-term levels reported in an acute MI population. 18 The strength of the study is the prospective design with limited exclusion criteria, which provides a quite representative group of patients with stable symptoms and a suspected diagnosis of CAD who were referred to the catheter laboratory for further follow-up. Another strength of the study is the high response rate on the standardized instruments during follow-up; 78% of the patients returned the questionnaire after 12 months. Nevertheless, the missing data can introduce bias and possibly underestimate the effects of having the diagnostic result disclosed.
Conclusion
Our results of prospective follow-up after 6 months and 1 year demonstrate that the homogeneous group of patients with normal coronary arteries or minimal coronary disease/non-obstructive coronary disease do not seem to benefit from information received about their coronary status in relation to the level of anxiety and depression in a manner similar to patients with significant obstructive stenosis. More research on endothelial function tests, risk factor modification, optimal medical intervention, and follow-up is warranted in this large group of patients.
